Evidence map›Paper›PMID 35590375›Full record

ArticleHarm reduction journal2022

Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study.

Jenny Corser, Heather Palis, Mathew Fleury, Jess Lamb, Kurt Lock, Jenny McDougall, Amiti Mehta, Cheri Newman, Heather Spence, Jane A Buxton

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Self-Care in Addiction Recovery: A Scoping Review.International journal of mental health nursing · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jenny CorserBC Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Heather PalisBC Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Mathew FleuryFaculty of Health Sciences, SFU, Blusson Hall, Room 11300, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
Jess LambPEEP- BC Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Kurt LockBC Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Jenny McDougallPEEP- BC Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Amiti MehtaBC Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Cheri NewmanPEEP- BC Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Heather SpenceKANDU - Kelowna Area Network of Drug Users, Kelowna, Canada.
Jane A BuxtonBC Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada. jane.buxton@ubc.ca.
BC Centre for Disease Control · CAKelowna General Hospital · CAProvincial Health Services Authority · CAUniversity of British Columbia Hospital · CA

Funding

CIHR 170288
6 · The paper itself

Abstract

backgroundBritish Columbia (BC) has been in a state of public health emergency since 2016, due to the unprecedented numbers of fatal and non-fatal drug toxicity (i.e. overdose) events. Methamphetamine detection in illicit drug toxicity deaths increased from 14% in 2012 to 43% in 2020 suggesting a concerning trend of concurrent methamphetamine and opioid use in BC, consistent with rising patterns identified across North America. People who use methamphetamine concurrently with opioids face an elevated risk of harm. This study aimed to identify behaviours for survival and wellness practiced by people who concurrently use methamphetamine and opioids.

methodsOne-on-one semi-structured interviews were conducted by peer research assistants in person and by telephone. Thematic analysis was carried out to identify patterns in behaviours participants described as important to their safety in the context of concurrent use of methamphetamine and opioids.

resultsParticipants (n = 22) were distributed across the province with at least four participants from each of the five geographic health regions: 64% self-identified as men, and 50% self-identified as Indigenous. Daily methamphetamine use was reported by 72.7% of participants, and 67.3% reported using alone either often or always. Participants made several considerations and adaptations in order to balance the perceived benefits and risks of their use of methamphetamine with opioids. Two overarching themes were identified to describe how participants adapted their use for survival and wellness. The first was personal safety behaviours which included self-regulation and self-care behaviours. The second was interpersonal safety behaviours which included using alongside peers, and engaging with peer-led services (e.g. community outreach organizations) and public health-led services (e.g. overdose prevention sites) to reduce the risk of harm. Participants identified many gaps in available services to meet their diverse needs.

conclusionsThis manuscript identified diversity in participants' methamphetamine and opioid use (i.e. frequency, route of administration), and a range of behaviours that were performed to improve wellness and survival while using methamphetamine and opioids. Harm reduction and treatment responses must be robust and adaptable to respond to the diversity of patterns of substance use among people who use methamphetamine and opioids concurrently, so as to not perpetuate harm and leave people behind.

Indexed as

Drug OverdoseDrug-Related Side Effects and Adverse ReactionsMethamphetamineOpioid-Related DisordersAnalgesics, OpioidBritish ColumbiaHumansMaleAnalgesics, OpioidMethamphetamineHarm reductionMethamphetamine useOpioid usePolysubstance useQualitative study

Identifiers

PMID35590375
PMCPMC9118627
OpenAlexW4280528658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.